School of Medicine
Showing 1-6 of 6 Results
-
Millie Das
Clinical Associate Professor, Medicine - Oncology
BioDr. Das specializes in the treatment of thoracic malignancies. She sees and treats patients both at the Stanford Cancer Center and at the Palo Alto VA Hospital. She is Chief of Oncology at the Palo Alto VA and is an active member of the VA national Lung Cancer Working Group and Lung Cancer Precision Oncology Program. In 2023, she was elected President the Association of Northern California Oncologists (ANCO), where she displays her passion for patient advocacy and also for clinician education by helping to organize Bay Area focused continuing medical education programs. She is the VA site director for the Stanford fellowship program and leads the VA thoracic tumor board on a biweekly basis. She has a strong interest in clinical research, serving as a principal investigator for multiple clinical and translational studies at the Palo Alto VA, and also as a co-investigator on all of the lung cancer trials at Stanford. In her free time, she enjoys spending time with her family, traveling, and running.
-
Jimbo Dickerson
Postdoctoral Medical Fellow, Oncology
Masters Student in Health Policy, admitted Autumn 2022
Fellow in Medicine
Resident in MedicineBioI am a medical oncology fellow with a clinical focus on breast cancer, and a research focus on examining cancer care delivery and resource allocation in both high- and low-income contexts. I am currently in my final year of fellowship, working on a Masters in health policy, and doing post-doctoral research on a T32 in the health policy department. My post-doctoral work is divided between domestic policy research, which focuses on analyzing cost and care variation, and global oncology projects, which concentrate on implementation and care delivery.
-
George Duran
Cancer Biologist and Laboratory Manager, Medicine - Med/Oncology
Current Role at StanfordCancer biologist specializing in the development of novel chemotherapeutic agents and in mechanisms of drug resistance. Current research ranges from molecular studies to further understand the heterogeneity of T-cell lymphomas, to translational studies of molecular determinants of therapeutic response, and clinical trials that use the body’s immune system to fight cancer cells.
Original research contributions have resulted in the authorship of over eighty publications.
